Colinz Laboratories Quarterly Results for Trading Insights

COLINZ • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹1 Cr
QMarch 2025
Quarterly Results

Colinz Laboratories Quarterly Results Key Highlights

  • Revenue of ₹7 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
  • Net Profit of ₹1 Cr in March 2025 (+0.0% vs March 2025, +0.0% vs March 2024)
  • EBITDA of ₹1 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 8.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹1.97 in March 2025 (+0.0% vs March 2025)

Colinz Laboratories Quarterly Results Analysis

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 6 7 7 7 7 -14.3% -
Net Profit (₹ Cr) 1 1 1 1 0 - -
EBITDA (₹ Cr) 1 1 1 1 1 - -
EPS (₹) 1.80 1.97 1.93 1.82 0.74 - -
Operating Margin (%) 7.0% 8.0% 8.0% 9.0% 8.0% - -

Colinz Laboratories Share Price Trend Around Quarterly Results

Visualize Colinz Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Colinz Laboratories share price chart using Tickjournal. All values in ₹.

Profitability Ratios

Profit Margin 14.3%
EBITDA Margin 14.3%
Operating Margin 8.0%
ROE (Annual) 10.0%

Balance Sheet Highlights

Total Assets ₹12 Cr
Total Equity ₹10 Cr
Current Assets ₹9 Cr
Current Liabilities ₹0 Cr

Cash Flow Analysis

Operating Cash Flow ₹-2 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹0 Cr
Net Cash Flow ₹-2 Cr

Current Market Data

Current Price ₹45.26
Exchange BSE
Last Updated Mar 02, 2026

Sector Competitors - Quarterly Performance Comparison

Comparing Colinz Laboratories quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025
₹416,764.48 Cr 1752.5 14,875 3,125 +10.8% - 21.0% 134.8
Divis Laboratories
Sept 2025
₹170,125.54 Cr 6403.5 2,860 689 +7.1% - 24.1% 246.6
Torrent Pharmaceuti…
Sept 2025
₹146,658.56 Cr 4369.2 3,219 591 +11.3% - 18.4% 249.1
Cipla
Sept 2025
₹109,178.44 Cr 1351.6 7,716 1,353 +12.0% - 17.5% 80.8
Dr Reddys Laborator…
Sept 2025
₹107,358.50 Cr 1294.4 9,135 1,337 +1.1% - 14.6% 80.0
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores